The Effectiveness of Perioperative CPAP to Reduce Obstructive Sleep Apnea Related Adverse Events
2013年12月17日 更新者：Dr. Frances Chung、University Health Network, Toronto
The Effectiveness of Perioperative CPAP to Reduce the Occurrence of Sleep Apnea Related Adverse Events in Surgical Patients With Obstructive Sleep Apnea
Objective of the study: To determine whether Perioperative Auto-CPAP treatment prevent postoperative worsening of OSA and improve nocturnal oxygen saturation in surgical patients with moderate and severe OSA.
研究概览
详细说明
The patients will be approached by the study coordinators at the preoperative clinic.
If the patient is interested in participating the study, STOP-Bang and Epworth questionnaires will be implemented to determine the risk for OSA.If the patients are classified as high risk of having OSA, they are scheduled for an overnight sleep study at home.
The patients with Apnea-Hypopnea Index (AHI)>15 from the sleep study will be randomized into two study groups: Perioperative CPAP group or control group (routine care).
In the perioperative CPAP group, patients will be treated with auto-CPAP for 2-3 nights preoperatively and 5 nights postoperatively.
All patients will undergo sleep study on the third postoperative night and be monitored by a pulse oximeter for 2-3 nights preoperatively and 5 nights postoperatively.
研究类型
介入性
注册 (实际的)
120
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。
学习地点
-
-
Ontario
-
Toronto、Ontario、加拿大、M5T2S8
- Toronto Western Hospital, Department of Aneshtesia
-
Toronto、Ontario、加拿大
- Mount Sinai Hospital, Department of Anesthesia
-
-
参与标准
研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
18年 至 80年 (成人、年长者)
接受健康志愿者
不
有资格学习的性别
全部
描述
Inclusion Criteria:
the patients who meet the following criteria will be recruited
- Patients who are scheduled for inpatient surgery that required a minimum of three nights of hospital stay
- Age: >18 and <80 years old.
- Identified as high risk of having OSA or diagnosed with OSA without using CPAP.
Exclusion Criteria:
- Undergoing nasal, eye, head/neck surgery, intracranial or cardiac/thoracic surgery.
- Unwilling or unable to give informed consent.
- Currently undergoing treatment for sleep apnea including CPAP.
- Requiring prolonged postoperative ventilation.
- New York Heart Association functional class III and IV.
- Having valvular heart disease, dilated cardiomyopathy, implanted cardiac pacemaker, or unstable angina.
- Having myocardial infarction or cardiac surgery within 3 months.
- Having chronic obstructive pulmonary disease, or asthma.
- Having a presence of tracheostomy, facial, neck, or chest wall abnormalities.
- Having abdominal aortic aneurysm surgery, chemotherapy, or immunosuppressive therapy within 3 months.
- Visiting preoperative clinic less than 3 days before scheduled surgery date.
- On nasogastric tube postoperatively.
学习计划
本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。
研究是如何设计的？
设计细节
- 主要用途：治疗
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：无（打开标签）
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
其他：CPAP Group
CPAP Treatment
|
Patients will be treated with auto-CPAP preoperatively for 2-3 nights preoperatively and 5 nights postoperatively during their sleep.
|
|
其他：Control Group
Routine care
|
Patients will be treated with auto-CPAP preoperatively for 2-3 nights preoperatively and 5 nights postoperatively during their sleep.
Patients in this group will receive routine care, undergo sleep study on the third postoperative night and be monitored by a pulse oximeter for oxygen saturation level for 2-3 nights preoperatively and 5 nights postoperatively during their sleep.
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Apnea-hypopnea index
大体时间：On the third night after surgery
|
Apnea-hypopnea index.
|
On the third night after surgery
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Nocturnal oxygen desaturation index (ODI) and percentage of time with SaO2<90%(CT90)
大体时间：2-3 nights before surgery and 5 nights after surgery
|
Nocturnal oxygen desaturation index (ODI) and percentage of time with SaO2<90%(CT90).
|
2-3 nights before surgery and 5 nights after surgery
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员：Frances Chung, FRCPC、University Health Network, Toronto
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始
2009年10月1日
初级完成 (实际的)
2011年10月1日
研究完成 (实际的)
2011年10月1日
研究注册日期
首次提交
2010年11月26日
首先提交符合 QC 标准的
2010年11月26日
首次发布 (估计)
2010年11月30日
研究记录更新
最后更新发布 (估计)
2013年12月18日
上次提交的符合 QC 标准的更新
2013年12月17日
最后验证
2012年7月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.